HA+ Trademark

Trademark Overview

On Wednesday, September 25, 2024, a trademark application was filed for HA+ with the United States Patent and Trademark Office. The USPTO has given the HA+ trademark a serial number of 98767760. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, September 25, 2024. This trademark is owned by Axogen Corporation. The HA+ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Implants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regenerati...

Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material; Chemical preparations for aiding implantation sold as an integral component of an implant comprising natural, non-living material; Chemical preparations for aiding implantation sold as an integral component of an implant comprising synthetic material
ha+

General Information

Serial Number98767760
Word MarkHA+
Filing DateWednesday, September 25, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesImplants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Chemical preparations for aiding implantation sold as an integral component of an implant comprising biological tissue
Goods and ServicesSurgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material; Chemical preparations for aiding implantation sold as an integral component of an implant comprising natural, non-living material; Chemical preparations for aiding implantation sold as an integral component of an implant comprising synthetic material

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2024
Primary Code005
First Use Anywhere DateMonday, December 5, 2022
First Use In Commerce DateFriday, May 12, 2023
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2024
Primary Code010
First Use Anywhere DateMonday, December 5, 2022
First Use In Commerce DateFriday, May 12, 2023

Trademark Owner History

Party NameAxogen Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33602

Trademark Events

Event DateEvent Description
Wednesday, September 25, 2024NEW APPLICATION ENTERED
Monday, December 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

tissue preparations repair veterinary implants sold comprising therefor pharmaceutical delivery